• $35,452.00
    Market Cap
  • 25.00%
    1-Year Change
  • Medical Devices
    Industry
Annual
Quarterly
10/31/2020
Income Statement
Total Operating Revenue
123,587
N/A
Cost of Revenue
51,817
N/A
Gross Profit
71,770
N/A
Sales and Marketing Expense
N/A
N/A
Research and Development Expense
-182,959
N/A
Depreciation and Amortization Expense
17,025
N/A
Total Operating Expenses
518,394
N/A
Operating Profit
-446,624
N/A
Interest Income
44
N/A
Interest Expense
-13,695
N/A
Interest Income and Expense and Net
-13,651
N/A
Total Nonoperating Income and Expense
-225,376
N/A
Income before Taxes
-672,000
N/A
Income Taxes
N/A
N/A
Extraordinary Items
N/A
N/A
Net Income
-672,000
N/A
Net Income from Continuing Operations Applicable to Common
-672,000
N/A
Basic EPS and Net Income
-0.01
N/A
Diluted EPS and Net Income
-0.01
N/A
Basic Weighted Average Shares
69.9M
N/A
Diluted Weighted Average Shares
70.1M
N/A
Balance Sheet
Cash and Cash Equivalents
201,664
N/A
Short-Term Investments
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
201,664
N/A
Total Current Assets
330,950
N/A
Accumulated Depreciation
446,949
N/A
Property and Plant and Equipment and Net
105,474
N/A
Total Long-Term Assets
138,276
N/A
Total Assets
469,226
N/A
Income Taxes Payable
374,650
N/A
Total Short-Term Debt
4.7M
N/A
Total Current Liabilities
7.9M
N/A
Total Long-Term Debt
N/A
N/A
Total Long-Term Liabilities
7,029
N/A
Total Liabilities
7.9M
N/A
Retained Earnings
-10.3M
N/A
Total Stockholders Equity
-7.4M
N/A
Total Shares Outstanding
70.2M
N/A
Cash Flow
Cash from Operating Activities
646,660
N/A
Capital Expenditures
30,706
N/A
Cash from Investing Activities
-30,706
N/A
Dividends Paid
N/A
N/A
Cash from Financing Activities
-427,821
N/A
Financials Ratio
Gross Margin
58.07%
N/A
Operating Margin
-361.38%
N/A
Return on Assets
-195.43%
N/A
Return on Equity
9.68%
N/A
Revenue Growth
960.20%
N/A
Current Ratio
0.04
N/A
Cash Ratio
0.03
N/A
Debt-to-Equity Ratio
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow